Adding Amgen's AMGN.O cholesterol drug Repatha to standard therapy reduced major cardiovascular events by 25% for at-risk patients who have ...
The Mobile Heart Walk was held Saturday morning on campus. Dozens of people gathered on the campus for the event. Fox Ten is the media sponsor and Lenise Ligon and other FOX 10 staff members were on ...
Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...
NEW ORLEANS, LA—Among patients with atrial fibrillation (AF) undergoing PCI, 1 month of dual therapy with a direct oral ...
An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...
For some people with high cholesterol, making lifestyle changes and taking routine cholesterol-lowering statin medications ...
The drug targets the PCSK9 protein, and could give millions of people a more affordable option to reduce their heart disease ...
One dose of an experimental drug cover offer lifetime treatment for people with high cholesterol, but its long-term safety is ...
12h
Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients ...
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers ...
The drug, given as a weekly subcutaneous injection, reduced both triglycerides and liver fat in the phase II trial.
NEW ORLEANS – A single injection of a gene-edited protein was deemed productive and safe in patients with dyslipidemia that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback